Intended Use

For In Vitro Diagnostic Use; EliA GBM is intended for the in vitro semi-quantitative measurement of IgG antibodies directed to α3 chain of collagen IV in human serum and plasma (Li-heparin, EDTA) as an aid in the clinical diagnosis of Goodpasture syndrome in conjunction with other laboratory and clinical findings.